logo
Select company
Select metric
$ -45KNet Cash Flow - Financing
VS
Market
48
Sector
73
Industry
86
History
100
$ 4.01Close
$ 1.25 - $ 4.32 52-Week Range
Ticker Information

Ticker

BDTX

Company Name

BLACK DIAMOND THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BLACK DIAMOND THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BDTX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ -45K
3/31/2025$ 21.45M
12/31/2024$ 25.55M
9/30/2024$ 25.21M
6/30/2024$ 97.39M
3/31/2024$ 76.01M
12/31/2023$ 71.93M
9/30/2023$ 71.95M
6/30/2023$ 75K
3/31/2023$ 75K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BLACK DIAMOND THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 297.61M.
  • Over the past 5 years, BLACK DIAMOND THERAPEUTICS INC's average CF - Financing has been $ 45.44M.
  • The median CF - Financing for BLACK DIAMOND THERAPEUTICS INC during this period was $ 1.67M
  • BLACK DIAMOND THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 297.61M.
  • The lowest CF - Financing recorded by BLACK DIAMOND THERAPEUTICS INC in the same timeframe $ -45K

BLACK DIAMOND THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
PLX : PROTALIX BIOTHERAPEUTICS INC $ -7.61MTHTX : THERATECHNOLOGIES INC $ -16.64MSGMO : SANGAMO THERAPEUTICS INC $ 43.54MALEC : ALECTOR INC $ 9.91MCSBR : CHAMPIONS ONCOLOGY INC $ 193KENTA : ENANTA PHARMACEUTICALS INC $ -25.51MSPRO : SPERO THERAPEUTICS INC $ 0AGEN : AGENUS INC $ 43.46MCELU : CELULARITY INC $ 4.51MIVVD : INVIVYD INC $ 279K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

BDTX - Net Cash Flow - Financing, Last 5 years

$ -45K

Minimum

Jun 30, 2025

$ 297.61M

Maximum

Sep 30, 2020

$ 45.44M

Average

$ 1.67M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M